Next Generation Sequencing
In just seven years, next-generation technologies have reduced the cost and increased the speed of DNA sequencing by four orders of magnitude, and experiments requiring many millions of sequencing reads are now routine.
Jay Shendure and Erez Lieberman Aiden, Nature Biotechnology October 2012
Dramatic improvements to commercial next-generation sequencing (NGS) platforms have resulted in spectacular reductions in the cost-per-base of DNA sequencing. Until recently, the primary focus for innovation has been on the core sequencing technologies, with optimization of sample preparation playing a secondary role. The exponential gains in sequencing capacity have led to growing sample throughput, increasing the demand for robust, streamlined, and automated library preparation and QC protocols for multiplexed sequencing across a range of sample types.
Our suite of innovative products for DNA and RNA sequencing workflows incorporate novel, high performance enzymes engineered via directed evolution and provide a complete solution for sample QC, library preparation, amplification and quantification. These products are compatible with all Illumina® and Ion Torrent™ sequencing platforms and optimized for demanding applications such as cancer tumor profiling that require sequence analysis of low-input, low-quality samples such as FFPE tissue.
Automated methods for library preparation and quantification are available for PerkinElmer Sciclone, Beckman FX, IntegenX Apollo, Agilent Bravo and Eppendorf epMotion. For more information please visit Automation Solutions.
- Whole genome sequencing
- Targeted sequencing
- Amplicon sequencing
- RNA sequencing
- ChIP sequencing
- Methyl sequencing
For Research Use Only. Not for use in diagnostic procedures.